[Relations Between Specific Neurochemical Systems and Memory: Problems Posed by Dementia of the Alzheimer Type]

Overview

Journal J Psychiatry Neurosci

Specialty Psychiatry

Date 1995 Jan 1

PMID 7865501

Authors

I LUSSIER

E Stip

Affiliations

Soon will be listed here.

References

Arendt T, Bigl V, ARENDT A, TENNSTEDT A . Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol. 1983; 61(2):101-8. DOI: 10.1007/BF00697388. View

WOOLLEY D, van der Hoeven T . Alteration in Learning Ability Caused by Changes in Cerebral Serotonin and Catechol Amines. Science. 1963; 139(3555):610-1. DOI: 10.1126/science.139.3555.610. View

Coyle J, Price D, DeLong M . Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 1983; 219(4589):1184-90. DOI: 10.1126/science.6338589. View

Wesnes K, Revell A . The separate and combined effects of scopolamine and nicotine on human information processing. Psychopharmacology (Berl). 1984; 84(1):5-11. DOI: 10.1007/BF00432014. View

Sunderland T, Tariot P, Cohen R, Weingartner H, Mueller 3rd E, Murphy D . Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study. Arch Gen Psychiatry. 1987; 44(5):418-26. DOI: 10.1001/archpsyc.1987.01800170032006. View

Crawshaw J, Mullen P . A study of benzhexol abuse. Br J Psychiatry. 1984; 145:300-3. DOI: 10.1192/bjp.145.3.300. View

Vecsei L, Bollok I, Penke B, Telegdy G . Somatostatin and (D-Trp8, D-Cys14)-somatostatin delay extinction and reverse electroconvulsive shock induced amnesia in rats. Psychoneuroendocrinology. 1986; 11(1):111-5. DOI: 10.1016/0306-4530(86)90037-5. View

Davis K, Mohs R . Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Am J Psychiatry. 1982; 139(11):1421-4. DOI: 10.1176/ajp.139.11.1421. View

Quirion R . Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release. J Psychiatry Neurosci. 1993; 18(5):226-34. PMC: 1188543. View

10.

Bickel U, Thomsen T, Weber W, Fischer J, Bachus R, Nitz M . Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition. Clin Pharmacol Ther. 1991; 50(4):420-8. DOI: 10.1038/clpt.1991.159. View

11.

Roffman M, Lal H . Role of brain amines in learning associated with "amphetamine-state". Psychopharmacologia. 1972; 25(3):195-204. DOI: 10.1007/BF00422501. View

12.

Koob G, Kelley A, Mason S . Locus coeruleus lesions: learning and extinction. Physiol Behav. 1978; 20(6):709-16. DOI: 10.1016/0031-9384(78)90296-2. View

13.

Harbaugh R, Reeder T, Senter H, Knopman D, Baskin D, Pirozzolo F . Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease. Results of a collaborative double-blind study. J Neurosurg. 1989; 71(4):481-6. DOI: 10.3171/jns.1989.71.4.0481. View

14.

Beal M, Mazurek M, Tran V, Chattha G, BIRD E, Martin J . Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease. Science. 1985; 229(4710):289-91. DOI: 10.1126/science.2861661. View

15.

Mohr E, Bruno G, Foster N, Gillespie M, Cox C, Hare T . GABA-agonist therapy for Alzheimer's disease. Clin Neuropharmacol. 1986; 9(3):257-63. DOI: 10.1097/00002826-198606000-00004. View

16.

Winter J, Petti D . The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory. Pharmacol Biochem Behav. 1987; 27(4):625-8. DOI: 10.1016/0091-3057(87)90184-5. View

17.

Berger B . [Neurotransmitter anomalies in Alzheimer's disease]. Rev Neurol (Paris). 1984; 140(10):539-52. View

18.

Gallagher M, Kapp B, Musty R, Driscoll P . Memory formation: evidence for a specific neurochemical system in the amygdala. Science. 1977; 198(4315):423-5. DOI: 10.1126/science.20664. View

19.

Mountjoy C, Rossor M, Iversen L, Roth M . Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia. Brain. 1984; 107 ( Pt 2):507-18. DOI: 10.1093/brain/107.2.507. View

20.

Enna S, Stern L, Wastek G, Yamamura H . Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders. Arch Neurol. 1977; 34(11):683-5. DOI: 10.1001/archneur.1977.00500230053008. View